On February 21, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. approved the following appointments to its Board committees: (i) Audit Committee Jeff Keyes (Chair), Carl Evans and Amy Mahery; (ii) Compensation Committee Dr. Jerzy (George) Gumulka (Chair), Jeff Keyes and Dr. Bettina Cockroft; and (iii) Nominating and Governance Committee Dr. Bettina Cockroft (Chair) and Faith Charles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | -35.21% |
|
-23.97% | -97.10% |
26/06 | Top Midday Decliners | MT |
26/06 | Wall Street Set to Open Marginally Lower Ahead of New Home Sales, GDP Figures | MT |
1st Jan change | Capi. | |
---|---|---|
-97.10% | 4L | |
+23.13% | 4.69TCr | |
+37.09% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |
- Stock Market
- Equities
- CNSP Stock
- News CNS Pharmaceuticals, Inc.
- CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees